BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 31284527)

  • 1. The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis.
    Madonna S; Girolomoni G; Dinarello CA; Albanesi C
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
    Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
    Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
    Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
    PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.
    Ahmad F; Alam MA; Ansari AW; Jochebeth A; Leo R; Al-Abdulla MN; Al-Khawaga S; AlHammadi A; Al-Malki A; Al Naama K; Ahmad A; Buddenkotte J; Steinhoff M
    J Invest Dermatol; 2024 Feb; 144(2):206-224. PubMed ID: 38189700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and function of interleukin-36 cytokines.
    Bassoy EY; Towne JE; Gabay C
    Immunol Rev; 2018 Jan; 281(1):169-178. PubMed ID: 29247994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
    Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
    Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions.
    Sachen KL; Arnold Greving CN; Towne JE
    Cytokine; 2022 Aug; 156():155897. PubMed ID: 35679693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and other Th17-mediated skin diseases.
    Tokura Y; Mori T; Hino R
    J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of IL-36 signature genes and individuals with
    Mahil SK; Catapano M; Di Meglio P; Dand N; Ahlfors H; Carr IM; Smith CH; Trembath RC; Peakman M; Wright J; Ciccarelli FD; Barker JN; Capon F
    Sci Transl Med; 2017 Oct; 9(411):. PubMed ID: 29021166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced NAMPT-Mediated NAD Salvage Pathway Contributes to Psoriasis Pathogenesis by Amplifying Epithelial Auto-Inflammatory Circuits.
    Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Avitabile D; Albanesi C; Madonna S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.
    Carrier Y; Ma HL; Ramon HE; Napierata L; Small C; O'Toole M; Young DA; Fouser LA; Nickerson-Nutter C; Collins M; Dunussi-Joannopoulos K; Medley QG
    J Invest Dermatol; 2011 Dec; 131(12):2428-37. PubMed ID: 21881584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic induction of IL-23 by TNFα, IL-17A, and EGF in keratinocytes.
    Ehst B; Wang Z; Leitenberger J; McClanahan D; De La Torre R; Sawka E; Ortega-Loayza AG; Strunck J; Greiling T; Simpson E; Liu Y
    Cytokine; 2021 Feb; 138():155357. PubMed ID: 33153894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
    Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
    J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions.
    Gabay C; Towne JE
    J Leukoc Biol; 2015 Apr; 97(4):645-52. PubMed ID: 25673295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
    Milora KA; Fu H; Dubaz O; Jensen LE
    J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.